US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates

Breanna Fernandes; Mark Christopher Navin; Dorit Rubinstein Reiss; Saad B. Omer; Katie Attwell

doi:10.1001/jama.2021.22122

US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates

Breanna Fernandes, Mark Christopher Navin, Dorit Rubinstein Reiss, Saad B. Omer, Katie Attwell

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	178-179
Number of pages	2
Journal	JAMA
Volume	327
Issue number	2
DOIs	https://doi.org/10.1001/jama.2021.22122
State	Published - Jan 11 2022
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2021.22122

Cite this

@article{0010eff03f1d454ea137a8e46dcbd0e3,

title = "US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates",

author = "Breanna Fernandes and Navin, {Mark Christopher} and Reiss, {Dorit Rubinstein} and Omer, {Saad B.} and Katie Attwell",

note = "Funding Information: Conflict of Interest Disclosures: Dr Reiss reported owning stock in GlaxoSmithKline and serving as an unpaid member of Moderna{\textquoteright}s advisory ethics committee. Dr Attwell is a member of the Australian Technical Advisory Group on Immunization COVID-19 working group 2 and is a current recipient of a Discovery Early Career Researcher Award funded by the Australian Research Council of the Australian government (DE19000158). No other disclosures were reported. ",

year = "2022",

month = jan,

day = "11",

doi = "10.1001/jama.2021.22122",

language = "English (US)",

volume = "327",

pages = "178--179",

journal = "JAMA",

issn = "0098-7484",

publisher = "American Medical Association",

number = "2",

}

TY - JOUR

T1 - US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates

AU - Fernandes, Breanna

AU - Navin, Mark Christopher

AU - Reiss, Dorit Rubinstein

AU - Omer, Saad B.

AU - Attwell, Katie

N1 - Funding Information: Conflict of Interest Disclosures: Dr Reiss reported owning stock in GlaxoSmithKline and serving as an unpaid member of Moderna’s advisory ethics committee. Dr Attwell is a member of the Australian Technical Advisory Group on Immunization COVID-19 working group 2 and is a current recipient of a Discovery Early Career Researcher Award funded by the Australian Research Council of the Australian government (DE19000158). No other disclosures were reported.

PY - 2022/1/11

Y1 - 2022/1/11

UR - http://www.scopus.com/inward/record.url?scp=85120743463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120743463&partnerID=8YFLogxK

U2 - 10.1001/jama.2021.22122

DO - 10.1001/jama.2021.22122

M3 - Letter

C2 - 34854872

AN - SCOPUS:85120743463

SN - 0098-7484

VL - 327

SP - 178

EP - 179

JO - JAMA

JF - JAMA

IS - 2

ER -

US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this